Related Experiment Video

Updated: Aug 12, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

[Bacterial infections of the lungs in mucoviscidosis patients]

M Hogardt1, J Heesemann

  • 1Max von Pettenkofer-Institut der LMU, München. hogardt@m3401.mpk.med.uni-muenchen.de

MMW Fortschritte Der Medizin
|March 5, 2005
PubMed

Insights

Lung infections in cystic fibrosis (CF) involve complex host and pathogen factors, with Pseudomonas aeruginosa being a key concern. Tailored microbiological diagnostics and advanced antibiotic strategies are crucial for managing chronic infections in aging CF patients.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Microbiology

Context:

  • Cystic fibrosis (CF) lung infections are complex, influenced by host and pathogen factors.
  • Pseudomonas aeruginosa is a primary pathogen driving CF lung disease progression and damage.
  • The clinical significance of other CF pathogens requires case-specific evaluation.

Purpose:

  • To emphasize the necessity of CF-specific microbiological diagnostics for optimal patient management.
  • To highlight the growing importance of chronic infection challenges in an aging CF population.
  • To underscore the critical role of inhalation antibiotics and combination therapy in the face of rising antimicrobial resistance.

Summary:

  • The pathogenesis of lung infections in cystic fibrosis (CF) is multifactorial, involving both host and pathogen elements.
  • Pseudomonas aeruginosa is identified as the most significant pathogen contributing to disease progression and pulmonary damage.
  • A tailored microbiological diagnostic work-up is essential for effective patient management, particularly as CF patients live longer and face increasing challenges with chronic infections and multidrug resistance.

Impact:

  • Informs clinical practice regarding the comprehensive diagnostic and therapeutic strategies needed for CF-associated lung infections.
  • Underscores the evolving landscape of CF care, focusing on chronic infection management and antimicrobial stewardship.
  • Provides insights into optimizing treatment outcomes through targeted antibiotic use in an era of increasing multidrug resistance.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections06:57

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections

Published on: May 8, 2017

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...